Children With ADHD Symptoms: Comorbid Conditions, Cognitive and Social Performance (NF ADHD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by University of Bergen.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Helse Fonna
Information provided by:
University of Bergen
ClinicalTrials.gov Identifier:
NCT01252446
First received: November 19, 2010
Last updated: December 2, 2010
Last verified: January 2009
  Purpose

This article reviews social-demographic variables (SDV) including interpersonal and academic and social performance in families and comorbid conditions(CC) which are the most associated with Attention-Deficit/Hyperactivity Disorder (ADHD)in the sample that has been confirmed diagnosis of ADHD and sample with the same symptoms but not confirmed diagnosis of ADHD.

There are no reports of this kind in the Norwegian population with ADHD.


Condition Phase
Comorbid Conditions
Social-demographic Profiles
Phase 1
Phase 2

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Children With ADHD Symptoms: Comorbid Conditions, Cognitive and Social Performance

Resource links provided by NLM:


Further study details as provided by University of Bergen:

Primary Outcome Measures:
  • Clinicians Manuals from Russell A. Barkley as Disruptive Behavior Disorders Rating Scale--Parent Form (Form 4), Disruptive Behavior Disorders Rating Scale--Teacher Form (Form 5) and Clinical Interview--Parent Report Form (Form 6) [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    The population was selected from a specialized outpatient clinic for Child and Adolescent Mental Health in Norway. ADHD referred children were classified in two groups: ADHD and non-ADHD. The data was obtained by examination of children and adolescent and by personal interviews and questionnaire with parents, teachers, children and adolescent with attention-deficit/hyperactivity disorder (ADHD).


Secondary Outcome Measures:
  • cognitive performance [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    Wechsler Intelligence Scale for Children-Revised (WISC-R)


Estimated Enrollment: 187
Study Start Date: September 2008
Estimated Study Completion Date: December 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
ADHD
The sample of 187 children and adolescent in the age of 6 to 17 years referred to the Child and Adolescent Clinic, Haugesund, Norway during the period of one year and diagnosed in ICD 10 system as ADHD.

Detailed Description:

ADHD is one of the largest diagnostic groups in psychiatric health care for children and adolescents in Norway. In the guidelines laid out by the central authorities, ADHD is to be prioritized. As can be seen by the attention this topic is given in the media, good diagnostics and treatment for this group are important for society as well as the individuals who suffer from this. Early diagnosis, proper organization and appropriate treatment have a positive effect on the self-esteem and development of the person diagnosed as well as probable socio-economic benefits for society.

ADHD population shows significant pattern in socio-demographic relations and comorbidity according to the population that is referred to community Mental Health Clinic due another types of psychiatric conditions.

In terms of comorbid states ODD and OCD are most associated with ADHD . The study indicates prevalence of ADHD children (74%) who met criteria for ADHD, Combined Type (ADHD-C, both inattention and hyperactivity-impulsivity symptoms) and the existence of generally low IQ measures with mean value of 85 points. In terms of comorbid states generally were found in almost whole ADHD group (93 %) compared to half of the non-ADHD group. Disruptive Behaviour Disorder, Anxiety /Stress related disorder and Encopresis /Enuresis shows significant difference between the groups. Other comorbid conditions show no significant differences. Social dysfunctions were found in four of five children.

  Eligibility

Ages Eligible for Study:   6 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

One hundred eihgty seven children and adolescent referred to a Child and Adolescent Mental Health Clinic in Haugesund, Rogaland, Norway with the sympthoms of innattentivity, hyperactivity and impulsivity. Ninety one of them has been diagnosed with ADHD by the ICD 10 Classification and Diagnostic system and ninety six has been diagnised with other diagnosis accordning to ICD 10 classification .

All referred children has been evaluated in this study. The diagnosis was made by child psychiatrist and relevant team and was based on the standard somatic and mental examination, information from the parents and teachers and diagnostics interviews.(Clinicians manual for assessment and parent training from Russell A. Barkley and SDQ-nor questionnaire ).

Criteria

Inclusion Criteria:

  • clinical symptoms related on diagnosis of ADHD
  • age from 6-17 years

Exclusion Criteria:

  • retardation
  • somatic disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01252446

Contacts
Contact: Nezla Duric, M:D: 004790544231 nezlad@gmail.com
Contact: Irene Elgen, M.D.PhD. 0047 irene.elgen@helse-bergen.no

Locations
Norway
Child and Adolescent Psychiatry Clinic Helse Fonna Haugesund Recruiting
Haugesund, Rogaland, Norway, 5500
Contact: Tove Vågen, CCORDINATOR    004752732800    Tove.Iversen.Vagen@helse-fonna.no   
Contact: Nezla Duric, M.D.    004790544231    nezlad@gmail.com   
Principal Investigator: Nezla Duric, M.D.         
Sponsors and Collaborators
University of Bergen
Helse Fonna
Investigators
Study Chair: Irene Elgen, m.d.PhD University in Bergen
Principal Investigator: Nezla Duric, M.D. University in Bergen
  More Information

Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Nezla Duric, MD, Child and Adolesc. Psych., University of Bergen, Child and Adolescent Clinic Helse Fonna
ClinicalTrials.gov Identifier: NCT01252446     History of Changes
Other Study ID Numbers: 219.04 REK, 219.04(REK)
Study First Received: November 19, 2010
Last Updated: December 2, 2010
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Norwegian Medicines Agency
Norway: Norwegian Social Science Data Services
Norway: Directorate of Health

Keywords provided by University of Bergen:
ICD 10
Attention-Deficit-Hyperactivity-Disorder (ADHD)
Comorbidity
Social-demographic profile

Additional relevant MeSH terms:
Disease
Pathologic Processes

ClinicalTrials.gov processed this record on September 30, 2014